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possible signiﬁcant external variable(s) separately or in combi-
nation. RESULTS: Twenty-ﬁve Chinese and 21 Indians (mean
(SD) age: 45.0 (15.55) years, 55.6% female) were interviewed.
Ethnicity was identiﬁed as the only independent variable causing
signiﬁcant difference in VAS (p < 0.05). RQoL, BTF, DOO, ITW
were found to explain the variation of VAS of 26.5%, 27.2%,
23.2%, 17.1% respectively in separate MLR models (p < 0.05).
Combining ethnicity together with the sum of AAs explained up
to 27.3% of the variation in VAS, while a model with ethnicity
alone only accounted for 10.7% (p < 0.05). When MLR was
done to examine different predicting power of AAs by ethnicity,
ITW failed to predict VAS of Indians (0.3%, p = 0.80) while the
other 3 AAs moderately explained from 9.1% to 22.9% of the
variation p < 0.05). CONCLUSIONS: EVM may be helpful in
explaining the variations in health preference and predicting
important factors.
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OBJECTIVES: Great debate exists over appropriate cost/QALY
thresholds. We assessed reporting of cost-effectiveness thresholds
in the literature to examine prevailing judgements about society’s
willingness-to-pay per QALY. We hypothesized that stated
thresholds were directly related to an author’s home country
GDP per capita and that they have increased over time to reﬂect
economic growth. METHODS: We evaluated 573 cost-
effectiveness analyses (CEAs) published between 1998–2003 and
listed in the Tufts-NEMC CEA registry. We scrutinized authors’
judgments regarding appropriate cost/QALY thresholds (e.g.,
that an incremental cost/QALY ratio under $50,000/QALY rep-
resents “good value for money”), and examined whether thresh-
olds differed by author’s home country GDP per capita (2000
values). RESULTS: CEAs most frequently originated from the US
(n = 320), UK (n = 68), Canada (n = 45), and The Netherlands
(n = 35). Of 573 studies, 325 CEAs (57%) stated an explicit
threshold. The most frequent thresholds used in the US were
$50,000/QALY (52%), followed by the classiﬁcation pro-
posed by Laupacis (CAN$20,000–CAN$100,000) (16%), and
$100,000/QALY (11%). Most Canadian studies (65%) used the
Laupacis classiﬁcation, and most UK studies (52%) used
GBP30,000/QALY. The prevailing US threshold ($50,000/
QALY) corresponded to approximately 1.4 times US GDP per
capita, whereas the UK threshold (GBP30,000/QALY) was
approximately 1.9 times UK GDP per capita. The lower and
upper limits of the Laupacis classiﬁcation used in Canada cor-
responded to 0.6 to 2.9 times Canadian GDP per capita. Thresh-
olds used by authors have not changed signiﬁcantly over time
and where not inﬂated to address inﬂation or economic growth.
CONCLUSIONS: Thresholds used in the US, UK, and Canada
do not appear to be related to GDP per capita, and have not
increased over time. More research is needed to determine appro-
priate country-speciﬁc or disease-speciﬁc thresholds. Mecha-
nisms for updating thresholds to reﬂect inﬂation rates or changes
in GDP are warranted.
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OBJECTIVES: The primary objective of this study was to deter-
mine the feasibility of an internet-based method for eliciting 
population based preferences for generic health states using the
standard gamble procedure. METHODS: An internet-based
standard gamble utilizing a chance board and a “ping-pong”
search procedure was introduced to twenty-ﬁve respondents who
were primarily recruited via e-mail solicitation. The respondents
were asked to elicit their preference for an EQ-5D generic health
state (21221). The same set of respondents were asked to elicit
their preference for their current health state using a internet-
based visual analog scale. RESULTS: Fifty-eight percent of the
25 respondents were male. Eighty percent of the respondents
were either health care professionals or academic-based health
service researchers, and the remainder were from the general
population. The majority of the respondents were White. Four
respondents were Hispanic and one was Asian. The mean age of
the respondents was 39.7 years. Both the standard gamble and
visual analog scale elicitation results were normally distributed
(Kolmogorov-Smirnov, p > 0.05). The mean elicited preference
for the generic health state using standard gamble was 0.8726
(s.d. 0.095), and the mean visual analog scale elicited preference
for the respondents’ current health state was 0.8721 (s.d. 0.088).
CONCLUSION: An internet-based approach for eliciting pref-
erence for a generic health state using a sophiticated standard
gamble procedure appears to be an efﬁcient means for perform-
ing such inquiry.
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OBJECTIVE: The objective of this study was to analyze the rela-
tionship between general health status and patient satisfaction
by conducting a meta-analysis on two previously conducted
studies. METHODS: Data collected from two cross-sectional
studies performed in 1997 and 2001 were pooled. Data collected
in 1997 was obtained from 737 patients taking a Selective Sero-
tonin Reuptake Inhibitor selected randomly from a prescription
claims database of a managed care company in Utah. Data col-
lected in 2001 was obtained randomly from 443 patients ﬁlling
prescriptions at 10 pharmacies located in the Houston, Texas.
General health status was measured using the SF-12 scale.
Patient satisfaction with the services provided by the health plan
was measured using an eight item scale. The satisfaction scale
across the two data sets was standardized to a 0–100 scale,
where a score of 100 was considered highly satisﬁed. Data were
coded and analyzed to report descriptive and correlation analy-
ses. RESULTS: The pooled dataset resulted in 1180 observations.
The mean age of the respondents was 47.02 ± 11.41 years (range
10 to 82) of which majority were females (72.6%). Data showed
that the respondents had low physical composite scores (PCS)
(48.34 ± 10.08) and mental composite scores (MCS) (46.39 ±
11.04) on the SF-12 scale. The mean patient satisfaction score
was 71.18 (± 17.89). Correlation analysis indicated there was no
association of either the PCS or the MCS with overall patient
satisfaction scores (p > 0.05). However, there was a positive asso-
ciation of individual items like health coverage provided by the
plan and out of pocket expenses paid by patient for health 
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services with the PCS (p < 0.05). CONCLUSION: The results of
this study indicate that general health status and patient satis-
faction are mutually exclusive variables. Further research is need
to understanding which attributes of patient satisfaction are cor-
related with general health status.
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OBJECTIVES: There is no standard method for providing
national benchmarks of dental care quality based on patient
reports, largely, because it is difﬁcult to create a survey that
covers all topics important to various stakeholders (dentists,
patients and dental care experts) while being short enough for
practical use. The purpose of this project was to use a multi-stage
qualitative research approach to involve stakeholders for the
purpose of developing a tool that would have value to very dif-
ferent audiences. METHODS: Speciﬁc features of dental care
were identiﬁed by a qualitative analysis of three, consecutive data
collections: 1) a search of the dental care quality assessment lit-
erature (which was dominated by clinical studies); 2) audio-tapes
of in-person interviews with dental care experts (primarily payers
and policy makers); and 3) audiovisual-tapes of focus groups
with dental patients. Questions to address each of 117 unique
features were drafted and organized into 20 topic areas. A
shorter version of this question list was created by choosing a
subset of questions that addressed just seven (of 20) topic areas
identiﬁed as the most critical aspects of care by both dental care
experts and dental patients. Finally, in-depth, “think-aloud”
interviews were used to determine the comprehensibility of the
questions and to assess whether they were interpreted as
intended. RESULTS: A 50-item questionnaire was developed
that describes: Dentist Communication, Technical Quality of
Care, Cleanliness of Ofﬁce/Clinic, Treatment Outcome, Access
to Necessary Care, Timely Access to Care, and Quality of Dental
Plan. CONCLUSION: A rigorous program of qualitative
research can be used to develop a content-valid, concise, yet com-
prehensive tool to provide data of potential value to a variety of
stakeholders. Subsequent research will evaluate the statistical
precision of data provided by this questionnaire in a pilot sample
of approximately 2100 dental patients.
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OBJECTIVES: Patient-reported Outcomes (PRO) are used in
clinical studies to assess patients’ treatment beneﬁt. There is an
increased interest in examining PRO claims included in approved
product labels. To date, there is no single database summarizing
PRO claims approved by the FDA or the EMEA by therapeutic
area, type of PROs or sponsors. In order to provide easy access
to this information, Mapi Research Trust and Mapi Values have
developed the PROLabels database. METHODS: Summary
Product Characteristics (SPC) of drugs approved through the
centralized procedure were gathered from the EMEA website
since January 1995. Approved labels of New Molecular Entities
posted on the FDA CDER website since January 1998 were also
examined. Only data pertaining to efﬁcacy endpoints were con-
sidered. Once a PRO claim was identiﬁed in an approved label,
the corresponding product was added to the database. Further
information displayed include: description of clinical studies sup-
porting the claim, the product’s pharmacological action, and
data source. RESULTS: At the date of December 21, 2005, the
database contains 121 records (57 from the FDA and 64 from
the EMEA) for 91 different International Nonproprietary Names
(INN). The ﬁve most represented therapeutic areas include
nervous (32.0%), immune (24.0%), musculoskeletal (18.0%),
genitourinary (14.8%), and respiratory (13.2%) systems. Signs
and symptoms are the most frequently measured PROs while,
HRQOL represents 20.7%. The database can be searched by
INN, commercial name, marketing authorization holder, indica-
tion, PRO, approval date, and agency. CONCLUSIONS: The
PROLabels database is a useful on-line tool to ﬁnd which prod-
ucts have obtained a PRO claim when reviewed by the EMEA
or the FDA. The database will be weekly updated. Other data
sources will be added to include PRO approved through the
mutual recognition/decentralized procedure in Europe and claim
approved in Canada.
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OBJECTIVES: To determine if item-level examination of 12-
month changes in quality of life (QOL) ratings gives qualitatively
different evidence that QOL change occurred as compared to dif-
ference in total scores. METHODS: A total of 258 AD patients
in a clinical trial of nonsteroidal anti-inﬂammatory agents
responded to 13 QOL items at two visits 12 months apart. A
simple difference (later–earlier) was calculated for total scores.
A qualiﬁed change algorithm was applied to the items: ratings
of “good” and “fair” were treated as indistinguishable and dif-
ferences per item were classiﬁed as one of four possible out-
comes: improved, worsened, stayed poor, and stayed “OK” (fair,
good, excellent). A Toulmin diagram permits evaluation of the
strength of evidence supporting a claim that “QOL changed”;
this method was used to compare evidence of QOL change from
the total score and item levels. RESULTS: “Signiﬁcant loss of
QOL” was observed in the treatment (each group mean < -1.0,
p < 0.05), but not the placebo (mean = -0.59, p > 0.3), groups.
Roughly 60% of all change in QOL items was worsening in each
arm; 17–42% of all subjects experienced change in each item.
CONCLUSIONS: Simple difference in total score over 12
months suggested little loss in QOL whereas qualifying change
suggested that at least 17% of any group experienced change on
every item with 60% of all change being worsening. A simple
difference summarizes estimated change, obscuring evidence that
change occurs. The Toulmin diagram suggests that more and
stronger evidence of change was obtained in a qualiﬁed change
approach, which reﬂects change as both improvement and wors-
ening and contemplates alternative explanations for observed
change. Qualiﬁed change provides more and stronger evidence
of change in subjective measures such as QOL.
